APA (7th ed.) Citation

Liu, S., Villaruz, L., Lee, V., Zhu, V., Baik, C., Sacher, A., . . . Camidge, D. (2020). LBA61 First analysis of RAIN-701: Study of tarloxotinib in patients with non-small cell lung cancer (NSCLC) EGFR Exon 20 insertion, HER2-activating mutations & other solid tumours with NRG1/ERBB gene fusions. Annals of Oncology, 31, S1189. https://doi.org/10.1016/j.annonc.2020.08.2294

Chicago Style (17th ed.) Citation

Liu, S.V, et al. "LBA61 First Analysis of RAIN-701: Study of Tarloxotinib in Patients with Non-small Cell Lung Cancer (NSCLC) EGFR Exon 20 Insertion, HER2-activating Mutations & Other Solid Tumours with NRG1/ERBB Gene Fusions." Annals of Oncology 31 (2020): S1189. https://doi.org/10.1016/j.annonc.2020.08.2294.

MLA (9th ed.) Citation

Liu, S.V, et al. "LBA61 First Analysis of RAIN-701: Study of Tarloxotinib in Patients with Non-small Cell Lung Cancer (NSCLC) EGFR Exon 20 Insertion, HER2-activating Mutations & Other Solid Tumours with NRG1/ERBB Gene Fusions." Annals of Oncology, vol. 31, 2020, p. S1189, https://doi.org/10.1016/j.annonc.2020.08.2294.